HUMAN PROOF OF CONCEPT
By Janelle R. Anderson
To listen to an audio podcast, mouse over the title and click Play. Open iTunes to download and subscribe to podcasts.
Every human needs medical treatment at some point. Yet the life sciences and venture capital industries – the dual engines driving medical discoveries – could scarcely be more specialized and exclusive. Human Proof of Concept is the podcast that demystifies the inner workings of venture-backed medical innovation, providing access and insights from the key players who shape the space. Listen in on the conversation with today’s business leaders, from VC partners to the biotech C-suite, exploring what they do and how they think. Hosted by Harvard PhD turned venture capitalist Janelle R. Anderson, Human Proof of Concept elucidates the ways in which the relative few bring new medicines, technologies, and hope to the many.
||The Art of Pappas||Art Pappas had an extensive, international career in the pharma industry before going on to form his eponymous VC firm in the 90s. Pappas Ventures has been partnering with pharma ever since: licensing assets from them,||3/31/2017||Free||View in iTunes|
||Stacey Seltzer on VC: Timing Timing Timing||If the mantra in real estate is location location location, for venture capital it might just be timing timing timing. Stacey Seltzer made the move from big pharma into venture capital during a financial crisis and has gone on to build a wildly diverse...||2/28/2017||Free||View in iTunes|
||Daily Digestif featuring Marc Pelletier||Marc was a podcaster before it was cool. That is, 2006. While producing over 100 hours of interviews on his show “Futures in Biotech” he confirmed his own future was in biotech, starting one and then another.||1/11/2017||Free||View in iTunes|
||Daily Digestif featuring Sara Demy||If Biotech Showcase is the farm team for JPM, then Sara Demy is the coach. She literally got high fives as her new conference burst onto the scene, bust out of its first two locations, and now boasts 400 presenting companies and 1,000 investors.||1/10/2017||Free||View in iTunes|
||Daily Digestif featuring Martin Lehr||After a run-in with Joe Biden’s entourage, Marty Lehr joined me on the first full day of the 35th Annual J.P. Morgan Healthcare Conference. He discussed his prior life at Osage University Partners, his current life at Context Therapeutics,||1/9/2017||Free||View in iTunes|
||Glen de Vries has his Head in the Cloud||In 1999 Glen de Vries started a tech company in his 5th floor walkup – very much the NYC equivalent of a garage in Silicon Valley. Today Medidata Solutions continues to transform human drug studies with their clinical cloud platform.||12/8/2016||Free||View in iTunes|
||Barry Kappel and Gerard Honig – Live!||Barry Kappel of Sapience Therapeutics and Gerard Honig of Symbiotic Health joined me for a fireside chat at the Foundation2016 conference. Held at Cold Spring Harbor Labs, it was a beautiful day in pre-election times.||11/17/2016||Free||View in iTunes|
||Stéphane Bancel: The Messenger is the Medium||Moderna is the Kendall Square startup developing a variety of drugs made of messenger RNA, leaving your cells to translate them into proteins. Forging a new ecosystem doesn’t come cheap: in only 5 years, Moderna has raised nearly $2B and is valued arou.||10/31/2016||Free||View in iTunes|
||Francois Nader: Be Small But Think Big||Today, Francois Nader is merely President of the Jesra Foundation, trustee of the New Jersey Chamber of Commerce, Chairman of Acceleron Pharma (XLRN), Director of ArRETT Neuroscience, Clementia Pharma, and Advanced Accelerator Applications (AAAP),||9/30/2016||Free||View in iTunes|
||Bill Newell: Sutro has an Unfair Advantage||Bill Newell is a lawyer turned large molecule wrangler. He’s CEO of Sutro Biopharma, and their special sauce – literally – lets them manipulate and manufacture antibodies with the kind of control scientists have had over small molecules for decades.||8/31/2016||Free||View in iTunes|
||Brian Bloom: Hockey Sticks and Cheerleaders Do Not Go Together||Home or away, Brian Bloom is recognized for his wildly successful conference and boutique investment bank. With a mission to uncover and cultivate Canadian life sciences companies through scientific focus and range of services, Bloom Burton & Co.,||7/31/2016||Free||View in iTunes|
||Kate Bingham, a Voice of Reason from the UK||Brexit isn’t the only newsworthy and dismal problem out there. Consider a couple of others – some VCs would rather not touch them with a ten foot pole, yet Kate Bingham is taking a stab at them: There’s Alzheimers. This past October,||6/29/2016||Free||View in iTunes|
||Sven Jacobson Doesn’t Have a Swelled Head||Have you heard the one about the guy who founded a biotech startup in the middle of Manhattan? Around a repurposed, hydrolysable, insoluble small molecule? To treat massive strokes, traumatic brain injury, and other neuro indications?||5/23/2016||Free||View in iTunes|
||CleanColin Cahill’s Venrock Diagram||Colin Cahill swears he didn’t grow up wanting to be a life science venture capitalist. But you would think he had planned it from his very first job cleaning glassware. His path from there to Venrock may appear linear after the fact,||4/30/2016||Free||View in iTunes|
||Greg Verdine will not take “undruggable” for an answer||Greg Verdine has evolved from merely being a Harvard prof, to consulting for big pharma, to starting biotech companies, to being a Venture Partner, and even to co-founding a non-profit institute – not just sequentially, but largely in parallel.||3/16/2016||Free||View in iTunes|
||The Multivalent Mathai Mammen||In the late nineties, a company named “Advanced Medicine” came together with the 4Cs of entrepreneurship in place: a concept, co-founders, capital, and some well-placed cold-calls. Mathai Mammen was one of those co-founders,||2/2/2016||Free||View in iTunes|
||Ron Cohen: Founder & Confounder (Part 1)||Ron Cohen has defied Venture Capital wisdom by founding Acorda Therapeutics over 20 years ago and remaining the CEO to this day. Originally hearing “no” from 70 VCs, he nevertheless grew the company into a public biotech worth nearly $2B today.||1/6/2016||Free||View in iTunes|
||Ron Cohen: Founder & Confounder (Part 2)||This past year, Ron took over the role of Chair of BIO, the Biotechnology Innovation Organization. From that vantage point, he comments on the high drama in 2015 that has entertained – and sometimes threatened – the industry.||1/6/2016||Free||View in iTunes|
||Introducing the New Podcast where VC meets Biotech||Welcome to Human Proof of Concept, the Biotech Venture Capital podcast hosted by Janelle R. Anderson.||1/4/2016||Free||View in iTunes|
Enjoyed the first few podcasts. Janelle has a defusing style that makes her guests relatable, and offers valuable insight into a complex field.